The device involved in this event has been received; however, the device evaluation has not yet begun.The available patient medical records and imaging studies have been received; however, the clinical specialist analysis has not yet begun.A follow-up report will be submitted upon completion of the device evaluation and the clinical analysis.
|
The patient was treated for an abdominal aortic aneurysm (aaa) with the implant of the alto abdominal stent graft system on (b)(6) 2023.Reportedly, upon attaching the auto injector to the alto main body, the syringe stopped at 6cc.The device was mounted on a terumo glidewire advantage which is not the normal stiffness.The physician found no relationship with the guidewire stiffness and the syringe stopping at 6cc.At approximately one minute the syringe was still stuck on 6cc.The physician took off the auto injector and re-attached it.This allowed the graft to fill, and it stopped at approximately 3cc.The patient¿s baseline pressure was 124 systolic.Approximately 5 minutes into gate cannulation it was noticed the syringe was empty and noted patient¿s pressure in the 70s and the certified registered nurse anesthetist (crna) began dosing benadryl and epinephrine.The patient pressure got up into the 80s.The graft still appeared filled.Patient pressure dropped back into the 70s occasionally over the next 3 minutes.Once the limb was attached and graft detached at 14 minutes, the crna had given a large quantity of epinephrine and patient pressure got up in the 230s.Gradually the patient pressure dropped into 160s and the case was finished.There were no apparent endoleaks.Post procedure the patient was stable with pressures in the 120s and was expected to be moved from recovery to the icu.The patient will continue to be monitored through routine follow-up visits.
|
The reported adverse event/incident was investigated in alignment with endologix operating procedures and work instructions.Where possible, it is endologix practice to make at least three good faith efforts to retrieve a reported adverse event/incident-related device as well as medical records and medical imaging.An evaluation of the manufacturing record was completed.A review of the part number/lot number combination needed for device identification shows the device to have been properly manufactured and released in accordance with the device master record.Endologix performed an evaluation of the returned alto delivery system.The device was received in a large shipping box, within the original product box within a biohazard bag.There was blood residue present on the device.The stent graft was not returned as it was implanted in the patient as reported.The 30ml polymer syringe was returned still attached to the polymer fill line and contained no polymer.The third knob and wire were returned.The delivery system was still within the sheath.The sheath was removed during decontamination.Visual analysis identified a single kink in the oval balloon fill line and the guidewire lumen at approximately 2.5mm proximal to the proximal lumen spacer.A 0.035" stiff guidewire was inserted into the alto delivery system, then the handle halves were separated to visualize the inner polymer fill line for presence of polymer.Polymer was found present on the distal end of the handle, near where the syringe is attached as well as on the proximal end of the tapered polyimide polymer lumen indicating a patent presence of polymer flow.The remainder of the device appears unremarkable.Based on the evaluation performed, the reported adverse event/incident `cannot be confirmed as the polymer leak may have originated in the graft itself which was not returned and remains implanted in the patient.A clinical evaluation of the adverse event/incident was completed.An examination of medical records and/or medical imaging received by endologix shows the intraoperative difficulty to dispense polymer complaint is unconfirmed.The intraoperative polymer leak with hypotension complaint is confirmed.This is moderately consistent with the reported adverse event/incident.Device, user, procedure or anatomy relatedness of this complaint could not be determined.No procedure related harms were identified.The final patient status was reported as discharged home on postoperative day one.No additional investigation of this reported adverse event/incident is planned.Endologix will continue to monitor this and similar adverse event/incident.H6: investigation type codes ¿ remove code 4118.H6: investigation finding codes - remove code 3233.H6: investigation conclusion codes - remove code 11.
|